norfloxacin nicotinate,
Norfloxacin nicotinate,
118803-81-9,
1-Ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid compound with nicotinic acid (1:1),
C22H23FN4O5,
3-Quinolinecarboxylic acid, 1,4-dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-, mono-3-pyridinecarboxylate,
3-Quinolinecarboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, mono-3-pyridinecarboxylate,
Norfloxacin Nicotinic,
nicotinic acid Norfloxacin,
AC1L36FA,
SCHEMBL4864800,
CTK8F0700,
KS-00000REC,
DTXSID10152246,
WRIFLTAYLRDENF-UHFFFAOYSA-N,
BCP13348,
MFCD00873666,
AKOS027322041,
API0024684,
AK312697,
DS-11847,
Quinabic soluble powder (TN) [veterinary],
LS-141593,
RT-014750,
FT-0631092,
D08287,
C-22382,
J-003889,
1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid; pyridine-3-carboxylic acid,
Quinoline-3-carboxylic acid,
C16H18FN3O3.C6H5NO2,
CID83908,
C16-H18-F-N3-O3.C6-H5-N-O2,